Endosense SA is a medical device company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias.
Granted the CE mark in May 2009, Endosense SA’s TactiCath® is the first and only force-sensing ablation catheter to give physicians a real-time, objective measure of contact force during the catheter ablation procedure.
TactiCath® has undergone considerable preclinical and clinical testing, the results of which have created a solid foundation of evidence supporting the feasibility, safety and value of contact force sensing during catheter ablation.
In August 2013 Endosense SA was acquired for total cash considerations of up to CHF309 million (USD331 million) by St. Jude Medical, Inc., a global medical device company (NYSE:STJ).
Location: Switzerland
Total raised: $105.536164M
Investors 2
Date | Name | Website |
- | NeoMed Man... | neomed.net... |
- | GIMV | gimv.com |
Funding Rounds 4
Date | Series | Amount | Investors | Deal News |
27.11.2013 | Series C | $41.185254... | - | startuptic... |
05.03.2013 | Series C | $4.3M | - | vcnewsdail... |
27.11.2012 | Series C | $40.3M | - | vcnewsdail... |
21.11.2005 | - | $19.75091M | NeoMed Man... | 3i.com/med... |
Mentions in press and media 21
Date | Title | Description | Source |
27.11.2013 | Endosense closes CHF 37.4 million series C round | Led by new investor NGN Capital, the round drew large participation from all existing investors, i... | startuptic... |
20.08.2013 | St. Jude Medical Acquires Endosense | St. Jude Medical (NYSE: STJ), a St.Paul, Minnesota-based a global medical device company, acquired E... | finsmes.co... |
19.08.2013 | St. Jude Medical acquires Endosense for up to CHF309 million | St. Jude Medical has made an initial payment of approximately 159 million Swiss francs ($170 milli... | startuptic... |
15.05.2013 | HRS13: Endosense’s force-sensing ablation catheter | Geneva-based Endosense’s proprietary contact force technology improves efficacy and safety of cathet... | massdevice... |
06.03.2013 | Endosense Secures Additional $4.3M in Series C Financing | Endosense, a Geneva, Switzerland-based medical technology company, secured an additional USD$4.3m (C... | finsmes.co... |
05.03.2013 | Endosense Closes an Additional $4.3M | GENEVA, SWITZERLAND, Pioneer and leader in contact-force sensing technology announced today that i... | vcnewsdail... |
05.03.2013 | Endosense raises additional CHF 4m | Endosense, a pioneer and leader in contact-force sensing technology focused on improving the effic... | startuptic... |
05.03.2013 | Endosense closes an additional USD 4.3 Million/CHF 4 Million... | Endosense, a pioneer and leader in contact-force sensing technology focused on improving the efficac... | neomed.net... |
06.02.2013 | First U.S. Case Performed with Endosenses Ablation Catheter... | The first U.S. case was performed by Dr. J. Michael Mangrum at University of Virginia Medical Cent... | startuptic... |
12.12.2012 | Endosense hires former Merck Sereno manager as CFO | Nicolas Marsault joins Endosense as it continues to expand the commercial presence of its TactiCat... | startuptic... |
Show more